FORA Capital’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-4,161
Closed -$231K – 565
2021
Q2
$231K Buy
4,161
+2,703
+185% +$144K 0.04% 408
2021
Q1
$68K Sell
1,458
-12,957
-90% -$628K 0.02% 489
2020
Q4
$627K Buy
+14,415
New +$532K 0.1% 238
2020
Q3
– Sell
-3,055
Closed -$89K – 782
2020
Q2
$89K Buy
+3,055
New +$84.4K 0.03% 521

Other funds holding HCAT

FORA Capital's HCAT Position: Q3 2021 in Review

FORA Capital sold out of Health Catalyst (HCAT) in Q3 2021, closing a stake of 4,161 shares — an estimated $231K sold.

FORA Capital first reported a position in HCAT in Q2 2020 and held it in 4 quarters. The position peaked at $627K in Q4 2020. 198 funds tracked by Wall St. Rank hold HCAT as of Q3 2021.

  • FORA Capital reported no remaining Health Catalyst position as of Q3 2021 after selling out during the quarter.
  • FORA Capital sold 4,161 Health Catalyst shares in Q3 2021, an estimated $231K.
  • FORA Capital first reported a position in Health Catalyst in Q2 2020 and held it in 4 quarters.
  • FORA Capital's Health Catalyst position peaked at $627K in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.